Core Viewpoint - The article highlights CONMED (CNMD) as a strong value stock opportunity, supported by various financial metrics indicating it is undervalued compared to its industry peers [4][8]. Financial Metrics - CNMD has a Zacks Rank of 2 (Buy) and a Value grade of A, indicating strong potential for value investors [4][3]. - The stock's P/E ratio is 10.69, significantly lower than the industry average of 18.29, suggesting it is undervalued [4]. - CNMD's PEG ratio stands at 1.62, compared to the industry average of 1.85, indicating favorable earnings growth expectations [5]. - The P/S ratio for CNMD is 1.02, lower than the industry average of 1.38, reinforcing its undervalued status [6]. - The P/CF ratio is 8.23, well below the industry average of 18.79, highlighting strong cash flow relative to its peers [7].